It is notable that while certain NBN variants have previously been reported to increase breast cancer risk [66], the most recent evidence from a large-scale case–control analysis refutes (OR 0.90, 95% CI 0.67–1.20) an association of truncating NBN variants with breast cancer risk [67]. This evidence concerns the gene NBN and breast carcinoma.